Instrument Business Outlook Volume 30 - Issue 7

15 Jul 2021

Categories:

Instrument Business Outlook

Table of Contents

Scientific Tool Industry’s R&D Spending Remains Steady Despite a Difficult Year
- Sales & R&D Growth
- R&D as a Percentage of Sales
- Conclusion
General and Environmental Labs: An Essential Market for Water Safety Testing Instruments
- General and Environmental Lab Trends
- PFAS
- Instrument Demand
- Opportunities in the Water Testing Space
- Direct-to-Consumer Testing
Executive Briefing
- EU to Request Concessions from Ilumina
- Sartorius Increases Quarterly and Annual Forecasts
- Sartorius Builds Cell and Gene Therapy Business
- QIAGEN Lowers Full-Year Revenue Guidance
- Renishaw No Longer for Sale
- Abbott to Sell STARLIMS
- Techcomp Expands Surface Science Offerings
- CELLINK Buys Microscopy Firm
- NGS Bioinformatics Firm Joins IPO Frenzy
- Flow Cytometer Maker to Go Public
First Quarter Results: HORIBA, Oxford Instruments and Pacific Biosciences
- HORIBA Optimistic About 2021 Yet Expects Procurement Challenges
- Oxford Instruments Concludes Fiscal 2021 in Positive Territory
- Pacific Biosciences Post Strong Instrument Sales
Market Profile: Zeta Potential Analyzers
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Consumer
- Biotech
- Government
Region Watch
- China
- Germany
- Switzerland
News
- Chromatography
  - Company Announcements
  - Product Introductions
- Life Science Instruments
  - Company Announcements
  - Product Introductions
  - Gene-based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
  - Cell-based Analysis
  - Company Announcements
  - Product Introductions
  - Protein-based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Surface Science
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Informatics
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
Bottom Line

Attachments

IBO 071521 Issue.pdf